Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
about
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based ReviewChallenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsInflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges.Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Beyond serotonin: newer antidepressants in the future.Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periodsGLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.Glutamatergic Mechanisms Associated with Seizures and Epilepsy.New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity.Rapid Resolution of Grief with IV Infusion of Ketamine: A Unique Phenomenological Experience.Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.Ionotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex.Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.Anaesthesia for electroconvulsive therapy - new tricks for old drugs: a systematic review.Gene expression related to serotonergic and glutamatergic neurotransmission is altered in the flinders sensitive line rat model of depression: Effect of ketamine.S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms.Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders.Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.Engaging homeostatic plasticity to treat depression.Hippocampal Acetylation may Improve Prenatal-Stress-Induced Depression-Like Behavior of Male Offspring Rats Through Regulating AMPARs Expression.Echinocystic acid reduces reserpine-induced pain/depression dyad in mice.Hydrogen sulfide functions as a neuromodulator to regulate striatal neurotransmission in a mouse model of Parkinson's disease.Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.The Role of Magnesium in Neurological Disorders.Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine TreatmentMetabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging StudyAcupuncture modulates stress response by the mTOR signaling pathway in a rat post-traumatic stress disorder modelElevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
P2860
Q26743786-0E0402A7-3AAE-41DA-9CA2-B6282C663626Q26782997-F1518092-FF0D-4859-8DDA-D7A89A8FF686Q31141746-2A09DFA6-5BA3-402A-BCF8-E35C2915BABFQ33857841-22FC9F9E-FA45-472E-8F29-DC7B964CF0E6Q33945211-16F1FB9E-878D-4AA0-A65C-B47A1002BFA9Q34241455-48483885-56C6-469D-B4D3-382EB1002BA1Q34551188-053CF720-98A7-4F4E-82D1-B0D458CF220BQ34557706-6D3BF400-6FDE-4B72-84AB-45DBE141FF94Q35103802-7D9C345E-8E2F-411C-A8A6-4A68D4222317Q36486035-AF870D11-EBB3-428A-A1BB-85053B256039Q38535033-52852DC7-97C0-4998-AA5F-E40ACADFB2B1Q38685420-1D9C12AC-0844-4B96-9333-1DDDDF75A46CQ38838307-F2B65A59-0A6C-4D52-AEF6-C63A67AE926BQ38838637-3CA22FDF-AABF-42EA-BB6B-82A0C5A0CDC9Q38936972-D0437B68-69FE-489E-9AC4-67CD06E04663Q38954648-1B95547F-143C-4203-8785-95A79CF51D8AQ39006965-5F696340-76C0-4F3F-BBB8-4543A803F4ECQ39277715-902154F6-2028-4B44-BBAD-5E92B235AD7FQ39427905-737750BE-679A-45A1-B37F-1871BB568F27Q41050258-BE20A8DE-49F7-41AB-B963-862982896042Q41729281-E0C4B7CE-6500-4B70-8B43-A43D126E632AQ43086364-2B770BC2-A60A-4DA9-8F48-770D01A97D1AQ47383203-40D61540-0AA9-4B54-B216-E6ED55E7E6FDQ47406465-39412657-3B44-4B74-8F34-C96212C82FD2Q47743181-D2FE0538-0E26-4500-9E42-2EF3B1EDC264Q48067098-4585CA36-67C7-4490-A9BD-AFB36F234467Q48459131-41979FCA-DC9E-4707-BE43-DA6C4D5B76C5Q51766804-6C54CFAA-5133-436B-864F-2403BDCA60F3Q55515107-B1566AF5-7A3E-4BB2-943D-96D1190CEB85Q58213868-F3FC60B2-99D5-443F-9138-71C7DF1DC784Q58213887-ABFB21C0-971D-4B1D-89CC-788F12335FECQ58796047-52CE7661-73A3-43A2-B375-3062FE7A4C5CQ59128157-C263992A-B9EE-4593-91BE-FC2F46B0BE49
P2860
Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Glutamate and its receptors in ...... t of major depressive disorder
@ast
Glutamate and its receptors in ...... t of major depressive disorder
@en
type
label
Glutamate and its receptors in ...... t of major depressive disorder
@ast
Glutamate and its receptors in ...... t of major depressive disorder
@en
prefLabel
Glutamate and its receptors in ...... t of major depressive disorder
@ast
Glutamate and its receptors in ...... t of major depressive disorder
@en
P2093
P2860
P1476
Glutamate and its receptors in ...... t of major depressive disorder
@en
P2093
Carlos A Zarate
Dawn F Ionescu
Erica M Richards
P2860
P2888
P304
P356
10.1007/S00702-013-1130-X
P50
P577
2013-12-08T00:00:00Z